Dynamics of CTCF-and cohesin-mediated chromatin looping revealed by live-cell imaging M Gabriele, HB Brandão, S Grosse-Holz, A Jha, GM Dailey, C Cattoglio, ... Science 376 (6592), 496-501, 2022 | 237 | 2022 |
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction M Gabriele, AT Vulto-van Silfhout, PL Germain, A Vitriolo, R Kumar, ... The American Journal of Human Genetics 100 (6), 907-925, 2017 | 138 | 2017 |
The chromatin basis of neurodevelopmental disorders: Rethinking dysfunction along the molecular and temporal axes M Gabriele, AL Tobon, G D'Agostino, G Testa Progress in Neuro-Psychopharmacology and Biological Psychiatry 84, 306-327, 2018 | 100 | 2018 |
Imbalanced autophagy causes synaptic deficits in a human model for neurodevelopmental disorders K Linda, EI Lewerissa, AHA Verboven, M Gabriele, M Frega, ... Autophagy 18 (2), 423-442, 2022 | 57 | 2022 |
Tracking and interpreting long-range chromatin interactions with super-resolution live-cell imaging HB Brandão*, M Gabriele*, AS Hansen Current Opinion in Cell Biology 70, 18-26, 2020 | 55 | 2020 |
CHD8 haploinsufficiency links autism to transient alterations in excitatory and inhibitory trajectories CE Villa, C Cheroni, CP Dotter, A López-Tóbon, B Oliveira, R Sacco, ... Cell Reports 39 (1), 110615, 2022 | 44 | 2022 |
High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11. 23 microduplication autism spectrum disorder patient-derived … F Cavallo, F Troglio, G Fagà, D Fancelli, R Shyti, S Trattaro, M Zanella, ... Molecular autism 11, 1-18, 2020 | 27 | 2020 |
Benchmarking brain organoid recapitulation of fetal corticogenesis C Cheroni, S Trattaro, N Caporale, A López-Tobón, E Tenderini, ... Translational Psychiatry 12 (1), 520, 2022 | 16 | 2022 |
Germline mutations in DNA repair genes may predict neoadjuvant therapy response in triple negative breast patients L Spugnesi, M Gabriele, R Scarpitta, M Tancredi, L Maresca, G Gambino, ... Genes, Chromosomes and Cancer 55 (12), 915-924, 2016 | 16 | 2016 |
From enhanceropathies to the epigenetic manifold underlying human cognition A Vitriolo, M Gabriele, G Testa Human Molecular Genetics 28 (R2), R226-R234, 2019 | 11 | 2019 |
Gabriele-de Vries Syndrome Synonym: YY1 Intellectual Disability Syndrome BV Sá, Maria J Nabais, Michele Gabriele, Giuseppe Testa University of Washington, Seattle, Seattle, WA.[Google Scholar], 2019 | 6* | 2019 |
KMT2D haploinsufficiency in Kabuki syndrome disrupts neuronal function through transcriptional and chromatin rewiring independent of H3K4-monomethylation M Gabriele, A Vitriolo, S Cuvertino, MF Pereira, C Franconi, PL Germain, ... bioRxiv, 2021 | 5 | 2021 |
YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer: A Critical Therapeutic Target B Bonavida Academic Press, 2020 | 1 | 2020 |
KMT2B and Neuronal Transdifferentiation: Bridging Basic Chromatin Mechanisms to Disease Actionability GT Giulia Barbagiovanni, Michele Gabriele Neuroscience Insights 15 (1–4), 2020 | 1 | 2020 |
YY1 mutations disrupt corticogenesis and cytoarchitecture through a cell-type specific rewiring of cell-autonomous and non-cell-autonomous transcriptional programs MF Pereira, V Finazzi, L Rizzuti, D Aprile, V Aiello, L Mollica, M Riva, ... bioRxiv, 2024.02. 16.580337, 2024 | | 2024 |
Tracing the Invisible Mutant ADNP protein in Helsmoortel-Van der Aa Syndrome patients CP D'Incal, E Cappuyns, K Choukri, K De Man, K Szrama, A Konings, ... | | 2023 |
Bayesian Inference of Chromatin Looping S Grosse-Holz, H Brandão, M Gabriele, A Jha, C Cattoglio, TH Hsieh, ... APS March Meeting Abstracts 2022, G18. 007, 2022 | | 2022 |
Molecular mechanisms of YY1 overexpression in human cancers and its prognostic significance M Gabriele, G Testa, A Hansen YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 123-147, 2021 | | 2021 |
The developmental logic of enhanceropathies caused by KMT2D and YY1 haploinsufficiency through patient-derived disease modeling platforms M Gabriele Università degli Studi di Milano, 2019 | | 2019 |
Definizione di una “signature” genetica correlata con la risposta alla terapia neoadiuvante in tumori della mammella triplo negativi con metodologia NGS. M GABRIELE | | 2013 |